Oral versus depot antipsychotic drugs for schizophrenia-A critical systematic review and meta-analysis of randomised long-term trials

Keyphrases

• Schizophrenia 100%
• Meta-analysis 100%
• Dropout 100%
• Depot 100%
• Non-adherence 100%
• Depot Antipsychotic 100%
• Antipsychotic Drugs 100%
• Adverse Events 66%
• Rehospitalization 66%
• Inefficacy 66%
• No Significant Difference 33%
• Cochrane Collaboration 33%
• Randomized Controlled Trial 33%
• Publication Bias 33%
• Exclusion Criteria 33%
• Limited Information 33%
• Methodological Issues 33%
• Cochrane 33%
• Relapse Rate 33%
• Cochrane Review 33%
• Random Effects Model 33%
• Non-adherent 33%
• Relative Risk Reduction 33%
• Risk of Bias Tool 33%
• Absolute Risk Reduction 33%
• Funnel Plot 33%
• Schizophrenia Treatment 33%
• Oral Antipsychotics 33%
• Depot Formulation 33%
• Randomization Method 33%
• Sources of Bias 33%
• Collaboration Risk 33%
• Depot Medication 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antipsychotic Drug 100%
• Schizophrenia 100%
• Adverse Event 50%
• Randomized Controlled Trial 25%
• Random Effects Model 25%
• Recurrence Risk 25%